Transform Chronic Disease Programs with Body Composition Data

Visceral fat directly affects insulin sensitivity. Lean mass influences glucose disposal. These body composition changes often precede diabetes diagnosis by years. Prism enables monitoring of these critical markers remotely, supporting prevention and reversal programs with objective outcome data.

Track visceral fat reduction, directly correlated with improved insulin sensitivity and glucose control

Monitor lean mass preservation during weight loss to prevent metabolic decline and maintain glucose disposal capacity

Demonstrate program effectiveness by tracking body composition changes over time with longitudinal data

Support diabetes remission programs with objective outcome data that proves metabolic improvements

Visceral fat contributes to hypertension independent of total body weight. Body fat distribution patterns (trunk vs. limb) predict cardiovascular risk. Prism quantifies these risk factors objectively, enabling programs to monitor cardiovascular health beyond blood pressure readings alone.

Track visceral fat, a key contributor to hypertension and cardiovascular disease independent of BMI

Monitor weight distribution patterns (trunk vs. limb fat) associated with cardiac risk and outcomes

Calculate body roundness index correlated with cardiovascular mortality risk in population studies

Demonstrate blood pressure program effectiveness with body composition improvements that support BP reduction

Visceral fat (the fat surrounding internal organs) is the most metabolically dangerous fat depot and a direct contributor to insulin resistance, hypertension, and cardiovascular disease. Unlike subcutaneous fat, visceral fat can't be assessed by BMI or scale weight. Prism quantifies it objectively without expensive CT or MRI scans.

Quantify visceral fat levels objectively without expensive imaging (CT, MRI) or in-person DEXA scans

Track visceral fat reduction in response to diet, exercise, or medication interventions, a leading indicator of metabolic improvement

Identify patients with high visceral fat despite normal BMI (metabolically unhealthy normal weight)

Motivate patients by showing reductions in dangerous "hidden" fat that they can't see in the mirror or on the scale

Treatment effectiveness varies by individual. Some patients respond well to interventions, others don't. Prism enables continuous monitoring of body composition responses to medications, lifestyle interventions, or combined approaches to identify non-responders who need treatment adjustments.

Track body composition changes in response to GLP-1s, metformin, lifestyle interventions, or combination therapies

Identify patients who are losing excessive muscle mass and need intervention adjustments or additional support

Monitor long-term treatment adherence through body composition trends that reflect lifestyle consistency

Generate outcomes data to demonstrate program ROI and clinical effectiveness to payers and stakeholders